2023-04-10 14:37:51 ET
- OncoSec Medical ( NASDAQ: ONCS ) is trading ~12 % higher after it said it had entered a $2M registered direct offering priced at-the-market.
- The company will purchase and sell 1.58M shares of its common stock at a purchase price of $1.25 per share.
- The company had also agreed to issue in a concurrent private placement unregistered warrants to purchase up to an aggregate of 1.58M shares at $1.12 per share.
- ONCS expects to use the net proceeds as working capital for general corporate purposes .
For further details see:
OncoSec rises 12% on $2M direct offering